Anvisa publishes a new procedure for medicines
Brazil’s Anvisa (National Health Surveillance Agency) has published a new standard operating procedure for Medicines, according to RDC 823/2023. The measure aims to reduce requirements for companies by 30%, focusing on quality in the registration and post-registration changes of synthetic and semi-synthetic medicines.
If you need more information about the regularization of your medicines, ELS can certainly help.
ontact your local ELS consultant or via email info@elssolutions.pt
